Yüklüyor......

Should an Institution That Has Commercial Rights in a New Drug or Device Be Allowed to Evaluate the Technology?

Background to the debate: In the United States, the passage of the Bayh–Dole Act in 1980 encouraged universities to license inventions for commercial development. Although this financial incentive can stimulate academic researchers to discover new drugs and devices, there is concern that the possibi...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: McKinney, Ross, Korn, David
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Public Library of Science 2005
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC545202/
https://ncbi.nlm.nih.gov/pubmed/15696219
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pmed.0020009
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!